In the BioHarmony Drug Report Database

"Preview" Icon

Moroctocog alfa

ReFacto AF (moroctocog alfa) is a protein pharmaceutical. Moroctocog alfa was first approved as ReFacto AF on 1999-04-13. It has been approved in Europe to treat hemophilia a.

 

Trade Name

 

ReFacto AF
 

Common Name

 

moroctocog alfa
 

ChEMBL ID

 

CHEMBL2109137
 

Indication

 

hemophilia a
 

Drug Class

 

Image (chem structure or protein)

Moroctocog alfa structure rendering